SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending following its earnings update, which signaled near-term caution due to anticipated supply constraints despite a strong prior quarter. This has sparked a polarized debate, with many community members labeling the sharp price movement as an expected correction for an overvalued asset, while bullish investors emphasize the company's long-term strategic importance in US chip manufacturing and potential future foundry partnerships.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending due to a confluence of regulatory news, including a key ruling restricting a prediction market in Massachusetts, alongside the NCAA's call for a federal halt on college sports betting. This has fueled widespread community debate over market manipulation, competitive dynamics, and whether recent dips present a compelling buying opportunity ahead of upcoming earnings.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending due to significant share purchases by CEO Ryan Cohen and news that Michael Burry will soon publish an update on the stock. The community is actively discussing the potential for a short squeeze, asserting that "shorts are trapped" and signaling strong conviction in the company's future. This surge in insider activity and renewed speculative interest continues to fuel intense anticipation among investors.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

Q/C Technologies Inc. (QCLS) is garnering significant market attention due to the recent appointment of a board member from OpenAI, fueling excitement around its quantum computing and AI initiatives. The community is sharply divided, with bulls highlighting its potential as an undervalued play in a cutting-edge sector, while skeptics point to historical profitability challenges and concerns about stock manipulation. This debate, alongside a recent reverse stock split, is driving elevated discussion and trading activity.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. (CRML) is experiencing heightened interest driven by its strategic involvement in Greenland's critical mineral resources and a significant Saudi Arabian joint venture to establish independent rare earth processing capabilities. The community is actively anticipating a potential short squeeze and discussing strong bullish momentum, with many expecting continued upward movement as geopolitical focus on critical mineral supply chains intensifies.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending amid significant optimism after new NOAA rules fast-tracked deep-sea mining applications, with the company filing for a consolidated exploration and commercial recovery permit. The community is highly bullish, viewing this as a critical move for US national security and mineral independence, anticipating rapid approval and significant future production, fueling expectations of a substantial upside and potential short squeeze.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano Inc. (MOVE) is experiencing intense trading activity as its merger partner, Corvex, announced a long-term NVIDIA H200 GPU deployment for AI workloads, igniting a fervent debate about its ultra-low float and potential for a significant short squeeze. While many anticipate substantial gains driven by AI infrastructure demand, a strong bearish contingent warns of previous pump-and-dump cycles and impending dilutions.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune (ALT) is trending due to surging interest in its MASH and obesity drug candidate, Pemvidutide, following its Breakthrough Therapy Designation and compelling phase 2 data, positioning it in a rapidly expanding market. The community is actively discussing significant re-rating potential or a strategic buyout, with high trading volume and speculation around partnerships driving much of the conversation.

AABG Token

AABBG CRYPTO is trending as the community eagerly discusses the company's federal lawsuit against market makers, alleging extensive stock manipulation. Investors anticipate a significant short squeeze, fueled by expectations for the upcoming launch of a new silver-backed cryptocurrency and an updated wallet. This sentiment is further bolstered by favorable market conditions for precious metals, supporting the value of the company's mining assets and the belief in substantial future gains.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending on the heels of compelling Phase 2 data in recurrent glioblastoma, where a significant majority of patients continue to show survival, defying typical expectations for this aggressive brain cancer and demonstrating immune system recovery. The community is actively discussing this breakthrough as a potential "paradigm shift" in cancer treatment, fueling fervent speculation about a looming short squeeze driven by high borrow fees and limited share availability as additional positive news catalysts approach.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PLTR $SMR $HIMS $IONQ $GME Quality meme stocks are always in high demand.👀🚀💰

$PLTR $SMR $HIMS $IONQ $GME Be patient with these quality meme stocks. Will always go to ATH at the next hype cycle.😊😉🚀

StockTwits For Android 

Palantir Technologies Inc

NuScale Power Corp

Hims & Hers Health Inc

IonQ Inc

 Quality meme stocks are always in high demand.👀🚀💰

@xifntx they are until they&#39;re really really not. that&#39;s why they&#39;re meme stocks

StockTwits Web

 they are until they're really really not. that's why they're meme stocks

Randy Galloup

@onceuponatime23 Yup but will 10x before they are not.

Forrest Gump

@xifntx PLTR already did that. it&#39;s down from here. i don&#39;t follow the other ones so idk

 PLTR already did that. it's down from here. i don't follow the other ones so idk